Abstract In this paper we study a reduced continuous model describing the local evolution of high grade gliomas -a lethal type of primary brain tumorthrough the interplay of different cellular phenotypes. We show how hypoxic events, even sporadic and/or limited in space may have a crucial role on the acceleration of the growth speed of high grade gliomas. Our modeling approach is based on two cellular phenotypes one of them being more migratory and the second one more proliferative with transitions between them being driven by the local oxygen values, assumed in this simple model to be uniform. Surprisingly even acute hypoxia events (i.e. very localized in time) leading to the appearance of migratory populations have the potential of accelerating the invasion speed of the proliferative phenotype up to speeds close to those of the migratory phenotype. The high invasion speed of the tumor persists for times much longer than the lifetime of the hypoxic event and the phenomenon is observed both when the migratory cells form a persistent wave of cells located on the invasion front and when they form a evanecent wave dissapearing after a short time by decay into the more proliferative phenotype.
Introduction

Malignant gliomas are the most frequent type of primary brain tumor. Between them, the most aggressive and prevalent glioma in adults is the glioblastoma multiforme (GBM), a grade IV astrocytic tumor (Wen and Kesari 2008) . Mean survival after GBM diagnosis is around 14 months using the standard of care which includes surgery to resect as much tumoral tissue as possible, radiotherapy and chemotherapy (temozolamide) (Mangiola et al. 2010) . Despite advances in understanding the complex biology of these tumors, the overall prognosis has improved only slightly in the past three decades.
The main reason for treatment failure is that the periphery of the GBM typically shows tumor cells infiltrating into the normal brain, frequently even in the contralateral hemispherium. Thus, even the so-called gross total resection of the tumor does not eliminate many migrating cells that cause tumor recurrence (Berens and Giese 1999; Onishi et al. 2011) , typically in less than six months after surgery (Giese et al. 2003) .
Pathological features of GBM are cellular pleomorphism, high cellular proliferation and diffuse infiltration, necrosis in the central regions of the tumor, microvascular hyperplasia and hypercellular areas surrounding necrotic areas around thrombosed vessels called pseudopalisades.
Due to the abnormal cell proliferation, the pre-existing vascular network is not able to appropriately feed the tumor cells. Angiogenesis emerges then in response to proangiogenic growth factors that are released by hypoxic cells in the tumor such as vascular endothelial growth factor (VEGF) (Ebos and Kebel 2011) . The end result of VEGF signaling in tumors is the production of immature, highly permeable blood vessels with subsequent poor maintenance of the blood brain barrier and parenchymal edema (Jensen 2009 ) leading to hypoxia.
Tumor hypoxia is generally recognized as a negative clinical prognostic and predictive factor owing to its involvement in various cancer hallmarks such as resistance to cell death, angiogenesis, invasiveness, metastasis, altered metabolism and genomic instability (Hanahan and Weinberg 2011; Ranalli et al. 2009 ). Hypoxia plays a central role in tumor progression and resistance to therapy (chemo-and radioresistance), specially in GBM, where it has been proven to play a key role in the biology and aggression of these cancers (Evans et al. 2004 ). These facts have motivated considering hypoxia as a therapeutic target in cancer. Some hypoxia-regulated molecules, including hypoxia inducible factor-1 (HIF-1), carbonic anhydrase IX, glucose transporter 1, and VEGF, may be suitable targets for therapies. HIF-1 is a regulator transcriptor of cell adaptation to hypoxia efficiently translated under normoxic and hypoxic conditions, however subunit HIF-1α contains an oxygen-dependent degradation domain which is rapidly degraded in normoxia.
Endothelial injury and prothrombotic factors secreted by glioma cells (Dutzmann et al 2010) lead to vaso-occlusive events. Following these events necrotic regions and waves of hypoxic cells moving away from the perivascular anoxic regions (Brat and Van Meir 2004; Martinez-González et al. 2012; Rong et al. 2006) are generated. Cells located in the perivascular areas have both oxygen and nu-3 trients and have a high proliferative activity. However, cells exposed to hypoxia display increased migration and slower proliferation to deal with a more aggressive environment (Das et al 2008; Elstner et al. 2007; Zagzag et al 2000) . This phenomenon has been called the go-or-grow dichotomy and studied in detail in gliomas (Giese et al. 1998 (Giese et al. , 2003 .
Many mathematical papers have used the concept of the migration-proliferation dichotomy to explain different aspects of the behavior of tumor cell populations in vitro or in vivo (Fedotov et al. 2011; Hatzikirou et al 2012; Iomin 2006; Martinez-González et al. 2012 , 2014 Pham et al. 2011; Stein et al. 2007; Tektonidis et al. 2011) . Specifically, several works have considered the role of hypoxia in gliomas finding a potential beneficial effect of its reduction via either the increase of the oxygen tension in the tumour (Hatzikirou et al 2012) or by the reduction of the occurrence of thrombotic events (Martinez-González et al. 2012 , 2014 .
In this work we complement previous studies and show that despite the initial idea of improving oxygenation is reasonable and well founded and may lead to better response to therapies, the effects of hypoxia may be more perverse than initially considered in previous works since even minimal amounts of hypoxic events may lead to accelerated progression in gliomas, even when oxygenation is rapidly restored and persistent for very long times.
The plan of the paper is as follows. First, in Sec. 2 we present the mathematical model, some preliminary theoretical results and discuss the parameter ranges of interest. In Sec. 3 we present the results of our numerical simulations showing the acceleration of invasion by waves of cells with an hypoxic phenotype. A detailed theoretical study with some rigorous results on travelling waves of the system under study is developed in Sec. 4. Finally in Sec. 5 we discuss the practical implications of our findings and summarize our results.
The Model
Derivation of the Model
Following the go-or-grow dichotomy concept we will describe the tumor as expressing two different phenotypes: a proliferative one to be denoted as u n (x, y) and a migratory one u h (x, y). We will consider that the force driving phenotype changes is the local oxygen pressure so that in hypoxic conditions tumor cells change to a mobile phenotype in a characteristic time τ nh and in normoxic conditions tumor cells acquire a proliferative phenotype in a time τ hn .
Detailed models of these processes have been proposed in several papers (see e.g. Martinez-González et al. (2012 , 2014 ). In this paper we will use a minimal model intended to capture the essentials of a striking phenomenon, the acceleration of tumor invasion due to sporadic hypoxic events.
We will assume that an initial hypoxic event around a capilar lasts a sufficient time for a complete phenotype switch to the migratory phenotype of the tumor cells located around it. This is reasonable because of the fast response The Model of HIF-1 under hypoxia, that induces phenotypic changes in a characteristic time of the order of minutes (Jewell et al. 2001 ).
Thus, we will take initially our tumor density to be of the form u n (x, t = 0) = 0, u h (x, t = 0) = u 0 h (x) and localized around a tumor vessel. Once oxygen supply is restored we will assume that oxygenation is maintained above the hypoxia level for all times, may be due to the action of a therapy normalizing vasculature, avoiding thrombotic events and/or increasing oxygenation. In that scenario the dynamics will be described by the equations
where D n , D h are the diffusion coefficients for the normoxic (proliferative) and hypoxic (migratory) phenotypes satisfying D h > D n and τ n , τ h are the doubling times for both phenotypes. This model is a pair of coupled FisherKolmogorov equations including a coupling term accounting for the decay of hypoxic cells into the normoxic phenotype with a characteristic time τ hn .
Global existence and boundedness of model's solutions
Let us first study the problem of global existence in time of non-negative solutions of Eqs. (2.1) with initial data u n (
h (x) and x ∈ R, t > 0. We will assume, in agreement with their biological meaning, that D n , D h , τ n , τ h , τ hn > 0 are finite real parameters.
Theorem 21 For any
) such that the parabolic problem (2.1) has a unique solution (u n (x, t), u h (x, t)) for 0 < t < T.
(ii) Any non-negative solution (u n (x, t), u h (x, t)) of (2.1), is a classical solution defined globally in time, and there are constants M 1 , M 2 such that
2 , the existence and uniqueness of mild solutions in C([0, T ); L 2 (R) 2 ) holds by the variation of constants formula and standard fixed points arguments. We take X = L 2 (R) 2 and A is the
Let us consider the fractional power spaces Henry (1981) ). In particular
so the hypothesis of Henry (1981, Theorem 3.3. 3) are verified and local existence and uniqueness follows.
(ii) Next, we will prove global existence for nonnegative solutions. To get the global bounds, we use standard comparison arguments. For any nonnegative solution we have that
, where V h (t) is the solution of the problem
hn then dV h /dt > 0 and therefore V h (t) will be an increasing function on [0, ∞), and upper bounded, consequently
hn then dV h /dt ≤ 0 and therefore V h (t) will be a decreasing function on [0, ∞), and lower bounded, consequently V h (t) ≤ V h (0) on [0, ∞), and (2.2b) holds. Moreover, for any positive initial data, V h (t) → 1 − τ h /τ hn as t → ∞.
For u n we get
where M 2 is given by (2.2b). Therefore, as in the previous case 0 ≤ u n (x, t) ≤ V n (t), where V n (t) is the solution of the problem
Let us choose u
The Model 1/4 + (M 2 τ n ) /τ hn then dV n /dt > 0 and therefore V n (t) will be an increasing function on [0, ∞), and upper bounded, consequently
hn then dV n /dt ≤ 0 and therefore V n (t) will be a decreasing function on [0, ∞), and lower bounded, consequently V n (t) ≤ V n (0). Moreover, for any positive initial data, V n (t) → 1/2 + 1/4 + (M 2 τ n ) /τ hn as t → ∞. Hence, inequality (2.2a) holds, which ends the proof.
Proposition 22 Assume that τ hn > τ n . The box
is an invariant box for (2.1), i.e. for any initial data (u 0 n , u 0 h ) ∈ Σ, then the solution of (2.1) (u n (x, t), u h (x, t)) ∈ Σ for any t ≥ 0.
Proof Taking f as given by Eqs. (2.3), assuming that (u n , u h ) ∈ Σ, and that τ hn > τ n , then
Therefore, Σ is an invariant box, see Smoller (1994, Section 14.B, p. 198 ).
Parameter estimation
Brain tissue has a complex structure with spatial inhomogeneities in the parameter values (e.g. different propagation speeds in white and gray matter) and anisotropies (e.g. on the diffusion tensor with preferential propagation directions along white matter tracts). In order to simplify the analysis and focus on the essentials of the phenomena to be studied we have chosen to study the model in one spatial dimension and in isotropic media. In Eqs. (2.1), the densities u n , u h are taken in units of the maximal tissue density, typically around 10 3 cell/cm. Although we will explore different parameter regimes, the normoxic cell doubling time will be taken to be τ n ∼ 24 h in agreement with typical cell doubling times in vitro (see e.g. Ke et al. (2000) ) and the hypoxic one τ h ∼ 48 h. The diffusion coefficients for normoxic and hypoxic cells will be taken to be around D n = 6.6·10 −12 cm 2 /s and D h around an order of magnitude larger (Martinez-González et al. 2012) . The parameter τ hn , corresponding to the phenotype switch time is harder to estimate since it corresponds to the recovery of the less motile proliferative phenotype under conditions of good oxygenation. The time of the opposite transition τ nh corresponding to the response time to hypoxia, despite some variability (Chi et al. 2006) , is a very fast time (Jewell et al. 2001) corresponding to the fast activation of the cellular adaptive responses to match oxygen supply with metabolic, bioenergetic, and redox demands (Majmundar et al 2010) . Normal cells have the capability of restoring their normal behavior once a hypoxic stimulus has finished. However, cancer cells may become more aggressive after cycles of hypoxia and reoxigenation (Bashkara et al. 2012) , and in some aspects the process may become at some moment irreversible leading to the so-called Warburg phenotype (Koppenol et al. 2011; Mendoza-Juez et al. 2012) . Typically short cycles of about 30 min of hypoxia and reoxigenation lead to the same (or even worse) outcome than under chronic hypoxia (Toffoli and Michielis 2008) leading to the conclusion that τ hn is larger than this value and thus τ hn ≫ τ nh . Different works point out to a normalization of the response to hypoxia between 48 h and 72 h. In vivo analysis of HIF-1α stabilization in well oxygenated tumor areas (Zagzag et al 2000) provides support for long normalization times τ hn .
To solve Eqs. (2.1) numerically we have used a standard finite difference method of second order in time and space with zero boundary conditions on the boundaries of the integration domain. We have used large integration domains and cross-checked our results for different sizes to avoid boundary effects.
Numerical results
Hypoxic events lead to fast glioma progression
An example of the phenomenon to be described here is presented in Figs. 1 and 2. There, an initial distribution of hypoxic tumor cells at t = 0, e.g. due to a transient vaso-occlusive event, is placed in a well oxygenated environment. One might expect naively that after a transient of about a few times τ hn , hypoxic cells would dissapear and then the front speed would tend asymptotically to that of the normoxic phenotype, given by the minimal FK speed
Although the hypoxic cell density decays and a front of normoxic cells is generated (see Fig. 1 ), the normoxic front propagation speed is not the minimal FK speed. In Fig. 2 we show pseudocolor spatio-temporal plots of u n (x, t) ( Fig.  2(a) ) and the front speed ( Fig. 2(b) ). The internal and external white lines show (respectively) the predicted evolution of purely normoxic and hypoxic initial data under no phenotype changes (i.e., the limit τ hn → ∞).
From the results shown in Fig. 2 it is clear that the speed of the propagating front of normoxic cells is not c * n but given by a substantially larger value even when the hypoxic cell population has become extinct (cf. Fig. 2(c) ). The simulation runs for long times to show that, although the hypoxic cell amplitude decays in a few days, its effect on the normoxic front propagation speed persists and provides a sustained front acceleration that is still present (though minimal) after one month of the initial (t = 0 − ) hypoxic event.
Waves of hypoxic cells drive the evolution of the normoxic component
To confirm that the acceleration of the normoxic phenotype front is due to the presence of the hypoxic component we have performed a second set of numerical experiments. In these simulations we have studied the effect of the suppression of the hypoxic component at a given time on the final propagation speed. Thus we have solved Eqs. (2.1) but setting artificially u h (x, t sup ) = 0 for different values of t sup .
The results are summarized in Fig. 3 . Note that for the simulations of Fig. 3 we have chosen a substantially smaller τ hn leading to a faster decay of the amplitude of the hypoxic component. It is remarkable that the asymptotic velocity increases with a longer presence of hypoxic cells even when the hypoxic wave amplitude is very small, it continues accelerating the front of normoxic phenotype cells. This behavior is somehow counterintuitive implying that the final normoxic wave speed more than doubles the expected speed c n . 
where X(t) = xun(x, t)dx. Shownare for comparison the speeds (calculated using the same formula) for purely hypoxic (upper dashed line) and purely normoxic cells (dashed lower line) without any type of transitions allowed between them. The long time scales shown guarantee that asymptotically the propagation of the normoxic front under an initial hypoxic event reaches an asymptotic speed essentially larger than the purely normoxic front. To understand this phenomenon let us note that initially the hypoxic wave propagates with speed
with c * h > c * n while at the same time decreases its amplitude providing a seeding of hypoxic cells that later change their phenotype to normoxic thus providing an extra source for normoxic cells. It is interesting that the phenomenon is mediated by a small amplitude wave of hypoxic cells. This leads to a substantially faster growth of the normoxic component when the wave reaches a specific location. Thus, the outcome of this dynamical phenomenon is that the effects of an initial hypoxic event may have a substantial influence on the invasion wave speed for very long timescales.
One may wonder if the outcome of our simulations may be due to the fact that the hypoxic initial distribution is not surrounded by normoxic tumor cells as it may happen in real tissue. To rule out this possibility we have run simulations with initial data localized around a vessel but surrounded by normoxic cells. An example of our results is shown in Fig. 4 ruling out the influence this choice on the asymptotic speed.
It is important to emphasize that the phenomenon described in this section occurs in broad parameter regions including the biologically relevant ranges of parameters. As an example, in Fig. 5 we plot the asymptotic speed as a function of the normoxic doubling time ranging from the typical in vitro values of τ n = 24 h to larger values closer to in-vivo doubling time estimates (Kirkby et al. 2007; Wang et al. 2009) 
Propagation regimes as a function of τ hn
The parameter τ hn describes complicated biological processes since it corresponds to the phenotype change of hypoxic cells under oxic conditions. As described in Sec. 2, this parameter can range from about an hour in normal cells to many days in transformed cells. One would expect that very fast decaying hypoxic phenotypes would lead to a smaller acceleration of the normoxic wave of invasion. In the opposite limit it is to expected that the asymptotic front velocity c ∞ satisfies lim τ hn →∞ c ∞ (τ hn ) = c * h . In Fig. 6 we explore the behavior of the asymptotic velocity of the normoxic wave one month after the hypoxic event for different values of the switch parameter τ hn . It can be seen how larger recovery times lead to asymptotic speeds closer to c * h .
Localized finite-amplitude wavepackets of hypoxic cells
It is very interesting that despite the instability of the hypoxic cells there are parameter regimes in which the hypoxic cells do not form an evanescent wave but instead a finite amplitude wavepacket of cells with the hypoxic phenotype persists leading the advance of the tumor.
Examples of typical results are summarized in Fig. 7 . As it can be seen in the pseudocolor plot of Fig. 7 (a) and in Fig. 7(c) , the hypoxic cell density does not vanish with time since their fast proliferation rates makes the zero solution unstable when the hypoxic wave hits the normal tissue areas. However, the hypoxic solution is unstable and decays into the normoxic one leading to a bright soliton of hypoxic cells (cf. Fig. 7(c) ) coupled to the front corresponding to the normoxic phenotype (Fig. 7(b) ). The speed of the resulting wave of hypoxic cells becomes asymptotically close to c * h . From the mathematical point of view these solutions correspond to stable homoclinic orbits of the system connecting with the equilibrium point u h = 0.
These families of solutions may correspond to the behavior of very aggressive phenotypes driven by hypoxia with both enhanced mobility and proliferation. In general, it is found in the context of different families of models that more aggressive phenotypes tend to be the drivers of invasion (Anderson et al. 2005; Ramis-Conde et al. 2008) . What it is interesting in the result described here is the fact that even an unstable phenotype such as the hypoxic one in a well oxygenated environment may lead to a robust non-vanishing wave.
Theoretical results
In the previous sections we have described several phenomena involving the existence of both decaying and localized travelling waves of hypoxic cells. In this section we wish to complement our numerical results with some theory on the existence of localized finite-amplitude waves of the system studied.
Let (u n , u h ) be a solution of (2.1). Under some assumptions on the parameters to be precised later, Eqs. (2.1) admit traveling wave solutions of the form
where prime denotes differentiation with respect to ξ. We will look for solutions v *
where v K denotes the classical KPP solution to the Fisher problem, see (Fisher 1937; Kolmogorov et al. 1937) , we get a solution of (4.1). It is well known that whenever c > c * n (or c < −c * n ), see (3.1a) for a definition of c * n , there exists a travelling wave
and satisfying 0
This solution corresponds to the heteroclinic orbit of the associated first order ordinary differential system, connecting the critical points (1, 0) with (0, 0). Here we will consider solutions with v h > 0 and analyze the associated first order ordinary differential system, see (A.1), and its critical points. We refer to the Appendix A for an study of the ODE, the equilibria and their corresponding stability, see Theorem A3, and Theorem A5 where we prove that (0, 0, 0, 0) is an stable equilibrium whenever τ hn > τ h , and (1, 0, 0, 0) is a saddle point with a 2-dimensional unstable manifold E u (and also a 2-dimensional stable manifold E s ). 
Theorem 41 Let us denote by
(4.5)
Let E u be the 2-dimensional unstable manifold of the equilibrium (1, 0, 0, 0) characterized in Theorem A5. Then, for any V 0 ∈ E u there is a trajectory
The proof will be presented later, in p. 18. Using this result we can move to the following Theorem, that proves the existence of a 2-dimensional manifold of initial data of heteroclinic trajectories of the associated ODE (A.1), connecting their corresponding critical points (1, 0, 0, 0) with (0, 0, 0, 0). This 2-dimensional manifold of initial data of heteroclinic trajectories, intersected
is a set of initial data of travelling waves. The idea of the proof is to choose a point on the unstable 2-dimensional manifold E u of the equilibrium (1, 0, 0, 0) and prove that, for some range of speeds, the trajectory falls down into the basin of attraction of (0, 0, 0, 0).
Theorem 42
Assume that τ hn > τ h and c > max{c * n , c * hn }, where c * n , c * hn are defined in (3.1a), (4.5) respectively. Let E u be the real 2-dimensional unstable manifold of the equilibrium (1, 0, 0, 0) characterized in Theorem A5.
Then, for any
there exists a travelling wave v * n , v * h solving (4.1), satisfying (4.2), and such that
Proof Let (v n , v h ) be a solution of (4.1) and
From Theorem 41, there is a real 2-dimensional manifold of the equilibrium E u such that, for any initial data
) satisfies the required conditions.
Theoretical results
Next, we plan to analyze the bifurcation from (v n , v h ) = (v K , 0) to get conditions for having v n , v h > 0. Let us denote by z = (z n , z h ) := (v n −v K , v h ), then z satisfies the equations
where, 7b) in order to avoid that 0 ∈ σ(L 1 ) or 0 ∈ σ(L 2 ), we add z n /τ n and z h /τ h respectively to both sides, consequently σ(
respectively, see Arendt and Batty (1993) . We look for solutions (z n , z h ) such that z n , (z n ) ′ , z h , (z h ) ′ → (0, 0, 0, 0) with z h > 0, as |ξ| → +∞. Let (z n , z h ) be a solution of (4.6) and let us define
where 
The following proposition states the asymptotic behavior of a solution of (4.8a), by using classical perturbation theory, see Coddington and Levinson (1955, Chapter 13) . We are going to see that the minimal speed wave of the hypoxic wave is given by c * hn , see (4.5) for a definition.
Proposition 43 Let Z = (Z 1 , Z 2 , Z 3 , Z 4 ), Z = Z(ξ), be a solution of (4.8a). Assume that τ hn > τ h . Assume also that c > max{c * n , c * hn }, where c * n , c * hn are defined in (3.1a), (4.5) respectively. Then (i) σ(A) := {λ 1± , λ 2± } ⊂ R, where λ 1± , λ 2± are defined in (4.10), µ +∞ := max σ(A) < 0, and the trivial solution is asymptotically stable. Moreover, if
where
and their eigenvalues satisfy the following inequalities λ 1− < 0 < λ 1+ , and λ 2− < 0 < λ 2+ . Moreover, there exists a real two-dimensional manifold S containing the origin, such that any solution Z of (4.8a) with Z(ξ 0 ) ∈ S for any ξ 0 , satisfy Z(ξ) → 0 as ξ → −∞, and
Moreover, there exists a C > 0 such that any solution Z near the origin, but not on S at ξ = ξ 0 can not satisfy
Proof This is a standard result in the theory of asymptotic behavior of ordinary differential equations (Coddington and Levinson 1955, Chapter 13) . We have to analyze the sign of Re(σ(A)) where σ(A) := {λ 1+ , λ 1− , λ 2+ , λ 2− }, and λ 1± , λ 2± are defined as
Obviously, if τ hn ≥ τ h , then c * hn ∈ R. Moreover, if c > c * n > 0, then the eigenvalues λ 1± are negative real numbers, and if c > c * hn , then the eigenvalues λ 2± are negative real numbers.
The eigenvalues of σ(A + B(−∞)) are given by
Whenever 0 < τ n < ∞, and τ hn > 0, the eigenvalues λ 1± , λ 2± are real numbers and satisfy λ 1− < 0 < λ 1+ , and λ 2− < 0 < λ 2+ .
Proof of Theorem 41. Let V = V (ξ; V 0 ) be a solution of the Eq. (A.1). From Theorem A5, there exists a real 2-dimensional unstable manifold of the equilibrium (1, 0, 0, 0) denoted by E u . In other words, for any V 0 ∈ E u , the trajectory
Let z = (z n , z h ) be a solution of Eq. (4.6). Since (z n , z h ) :
Also, from (4.4), for any ε > 0 there exists an ξ 1 ∈ R such that 
Next, we try to find necessary conditions for having a bifurcation from the trivial solution. Let us first pose the abstract framework of the problem.
A weak solution of
can be defined as usual: multiplying by a test function ψ = (ψ 1 , ψ 2 ) ∈ H 1 (R) 2 , and integrating on R, we obtain ∀ψ = (
Let us set H := H 1 (R) 2 with u H := u 1 2 + u 2 2 1/2 and define the bilinear form a : H × H → R given by
Theorem 44 Assume that min {D n , D h } > 0, and that 0 < τ n , τ h < ∞. Then, for all f = (f 1 , f 2 ) ∈ H * , the dual space of all linear continuous functional on H, there exists a unique u = (u 1 , u 2 ) ∈ H such that
and u H ≤ C f H * .
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The constant C can be chosen as
Proof The bilinear form a is continuous and coercive. Indeed, by definition (4.15) and since (Brézis 2011, Corollary 8.9) , we obtain
and thus u H ≤ C f H * with a constant C dependent only on α. The Lax-Milgram lemma completes this part of the proof.
By hypothesis
Moreover, by Brézis (2011, Corollary 8.9 
2 , since u, u ′ , v K , and f are continuous on R we get u ′′ ∈ C(R) 2 , and therefore u ∈ C 2 (R) 2 .
Finally, taking into account that u is a classical solution, we get (4.17) which completes the proof.
, denote the nonlinearity of (4.6), i.e.
We will say that z = (z n , z h ) ∈ H is a weak solution of (4.6) if and only if (4.6) is satisfied in a weak sense, which means that
The following result ensures that a weak solution is a classical solution, and provide the rates at ±∞.
Theorem 46 Assume that min {D n , D h } > 0, and that 0 < τ n , τ h < ∞. Assume that τ hn > τ h and c > max{c * n , c * hn }, where c * n , c * hn are defined in (3.1a), (4.5) respectively. Let z = (z n , z h ) ∈ H be a weak solution of (4.6).
Then the following holds:
and λ 1± , λ 2± , λ 1− , λ 2− are defined in (4.10), (4.11) respectively.
Proof i) By Morrey's Theorem, see Brézis (2011) , there is a constant C such that
e. x, y ∈ R, i ∈ {n, h}.
Moreover, due to z ∈ H, we get that z n , z h → (0, 0) as |ξ| → +∞. Therefore, applying Theorem 44, we complete this part of the the proof. ii) From part i) we get that z n , z ′ n , z h , z ′ h → (0, 0, 0, 0) as |ξ| → +∞ and therefore, applying Proposition 43 we conclude the proof.
Lemma 47 Assume that τ hn > τ h and c > max{c * n , c * hn }, where c * n , c * hn are defined in (3.1a), (4.5) respectively. Let (v n , v h ) be a nonegative solution of (4.1), with v n ≡ 0, v h ≡ 0. Then,
) is a solution of Eq. (4.6). Therefore, Lemma 47 implies that
Proof of Lemma 47. Let (v n , v h ) = (z n + v K , z h ) be a nonnegative solution of (4.1) with v n = 0, v h = 0. Note that v n , v h can only have simple zeros, in the sense that if
)/τ h and the inequalities related to v h in (4.20) are attained.
and therefore 1
and dividing by v n (x n ) > 0, we get v n (x n ) ≤ 1. Also v n (x n ) ≤ τ n /τ hn , and the inequalities related to v n in (4.20) are attained, completing the proof.
Finally, we move to one of our main results in this section that states necessary conditions for having solutions bifurcating from the solution (v K , 0) and positive in the second component, i.e. persistent finite amplitude solitons composed of cells with an hypoxic phenotype. Technically we use classical bifurcation methods. The convergence in any bounded interval is clear, and also that the limit function is a classical solution of the limit problem in all R. The difficulty comes when trying to prove that the convergence is, in fact, in all R and as a consequence, that the limit function is non-trivial.
To achieve it, we need uniform estimates of the H 1 norms in the exterior of bounded intervals. In particular, we have to control the behavior at ±∞. We overcome this difficulty by using perturbation theory in this framework.
The interesting asymptotic behavior is obtained when τ hn > τ h , and c > max{c * n , c * hn }, where c * n , c * hn are defined in (3.1a) and (4.5) respectively, see Appendix and Proposition 43.
Theorem 49 Let (Λ j , z j ) ∈ R 3 × H, be a sequence solving (4.6), with Λ j := (τ n,j , τ h,j , τ hn,j ) ∈ R 3 , and z j = (z n,j , z h,j ) ∈ H with z h,j > 0. Assume that z j L 2 (R) 2 → 0. Assume also that lim sup j→∞ τ h,j =: τ h > 0, that lim j→∞ τ hn,j =: τ hn > 0, that τ hn,j > τ h,j , and that c > max{c * n,j , c * hn,j }, for some subsequence again denoted by τ hn,j . Then,
Moreover, at least for a subsequence,
Theoretical results
and the function
From the Kolmogorov-Riesz-Fréchet's Theorem, see (Brézis 2011, Theorem 4.26 and Corollary 4.27) , for any bounded interval I fixed, there exists a subsequence Φ hj → Φ h in H 1 (I). If moreover, for any ε > 0, there exists a bounded interval I = I(ε) such that
then, there exists a subsequence such that
, where Φ h depends on R 0 , (we shall denote it by Φ h,R0 when we need to remark this dependence). In order to achieve (4.23), let us divide Eq. (4.6b) by z 2j L 2 (R) , then we obtain
hj ) be the solution of the associated IVP
and
Moreover, using (4.4) and since (z n,j , z h,j ) → (0, 0) as j → ∞, see Theorem 46, we get
Eq. (4.25) is an homogeneous linear problem. From classical perturbation theory (see Coddington and Levinson (1955) ), we get the asymptotic behavior lim sup
where λ 2+ , λ 2+ are defined in (4.10),(4.11) respectively. Therefore (4.23) is accomplished, Φ hj → Φ h in H 1 (R) and Φ h solves (4.21). In particular Φ h L 2 (R) = 1 which implies Φ h = 0, and then Φ h 0. The Maximum Principle implies that Φ h > 0.
Multiplying (4.21) by Φ h and integrating on R we obtain
so 1/τ h − 1/τ hn ≥ 0 which completes the proof.
Remark 410 The asymptotic behavior provided by (4.28a) is un upper bound. In the same sprit as Proposition 43, (ii), there exists a real one-dimensional manifold S 1 containing the origin, such that any solution
where A, B are defined in (4.26), and with (4.30) where λ 2− is defined in (4.10).
From a theoretical point of view, the hypoxic front wave can have two 'components' when ξ → ∞, one corresponding to the biggest eigenvalue λ 2+ , and the other one to the smallest eigenvalue λ 2− . From a quantitative point of view, the component corresponding to the biggest eigenvalue λ 2+ , is much bigger than the component corresponding to the smallest eigenvalue λ 2− . The above result states that the speed wave of the component of the hypoxic front wave corresponding to the smallest eigenvalue converges to c Assume that for any ε > 0 there exists a j 0 such that if j ≥ j 0 then lim sup 31) where λ 2−,j are defined in (4.10) for (τ h , τ hn , c) = (τ h,j , τ hn,j , c j ), then
Proof By hypothesis we have that c j > max{c * n,j , c * hn,j } ≥ c * hn,j . We shall argue by contradiction, assuming that c > c * hn . By definition of λ 2− , see (4.10), we can state that λ 2− < −c/2D h , therefore, taking into account (4.30), there exists some ε > 0 such that 33) Let ϕ := e αξ Φ h for some α to be determined later. Differentiating twice, substituting into the equation (4.21), and rearranging terms we can write (4.34) where σ = 1/τ h − 1/τ hn . Choosing α := c/2D h we get lim sup
We can consider this as a self-adjoint problem in L 2 (R), regardless of the original space, so that any eigenvalue must be real. The smallest eigenvalue is σ = inf
and therefore σ ≥ c 2 /4D h . Taking into account that σ = 1/τ h − 1/τ hn , we ob-
hn , which contradicts the hypothesis, ending the proof.
With respect to the first component, we can prove the following result.
Corollary 412 If the hypothesis of Theorem 49, hold, then
Moreover, Φ n ∈ C 2 (R)∩H 2 (R) is such that Φ n = 0, and for some θ ∈ [0, 1)
From the Kolmogorov-Riesz-Fréchet's Theorem, see Brézis (2011, Theorem 4.26 and Corollary 4.27) , for any bounded interval I fixed, there exists a subsequence
Dividing by z j L 2 (R) the first equation of (4.6), we obtain
Therapeutical implications and conclusions
Moreover, using (4.4) and the fact that (z n,j , z h,j ) → (0, 0) as j → ∞, see Theorem 46, we get
From (4.28), we get lim sup
where λ i± , λ 2+ , are defined in (4.10),(4.11) respectively. Eq. (4.38) is a non-homogeneous linear problem. From the variation of parameters formula, we get, as before, its asymptotic behavior lim sup
where λ i+ , λ i+ , i = 1, 2, are defined in (4.10),(4.11) respectively. Then Φ nj → Φ n in H 1 (R) and Φ n solves (4.35). If θ = 1 then Φ n L 2 (R) 2 = √ 1 − θ 2 = 0 which contradicts (4.35), due to Φ h L 2 (R) 2 = 1, so 0 ≤ θ < 1 and Φ n = 0.
Therapeutical implications and conclusions
Hypoxia is a characteristic feature of high-grade gliomas HGGs and arises first as a result of the proliferative activity of cells overcoming the capabilities of oxygen supply by the vasculature. In the case of gliomas there is an additional effect due to the secretion of prothrombotic factors that result in vessel failure. It is interesting to note that hypoxia is only marginal in low grade gliomas (Zagzag et al 2000) , where the vasculature remains mainly intact. Our results indicate that hypoxic events will result in an accelerated progression even when those hypoxic events are local in time, leading to a (may be diffuse and/or small in amplitude) front of invasive cells displaying the hypoxic phenotype (see e.g. Figure 3C of Zagzag et al (2000) ). This fact limits the potential efficacy of therapies targeting oxygenation alone, such as those described by Hatzikirou et al (2012) or Martinez-González et al. (2012) since it is not possible to stop completely the occurrence of hypoxic events in such an aggresive type of tumor.
Is there then an alternative to use re-oxygenation to favor the more proliferative yet less invasive phenotypes? The only possibility in the framework of the simple description used in this paper is to act on the switching time τ hn . In real situations τ hn is not constant but typically increases with the number of hypoxia cycles experienced by cells until they reach to a state of physical balance with HIF-1α. This sequence of oxygen deprivation episodes drives genetic alterations in tumor cells so that HIF-1α is accumulated in their nucleus even in oxic conditions and thus cells can not return to their previous state (Semenza 2003) . Therefore, τ hn becomes larger than the typical proliferation time. Once the cells take so much time to revert to their less motile state in oxic conditions, the speed of the front increases in a sustained way (see Fig.  6 ). In fact, in vivo analysis of HIF-1 stabilization in well oxygenated tumor areas (Zagzag et al 2000) supports long normalization times. However, if τ hn could be kept small, as it happens in the normal cellular physiological state, the tumor invasion speed would drastically decrease to c * n in oxic conditions. Thus, in order to be effective, a therapy involving enhanced oxygenation (or vascular normalization) should also act on HIF-1α equilibrium simultaneously. This fact, in addition to other reasons, may be a reason for the failure of antiangiogenic therapies that lead to a radiographic response and increase in the progression free survival (Friedman et al. 2009 ) but not to a real increase in survival of GBM patients (Butowski 2011) . Moreover it is known that in recurrent tumors the effect of antiangiogenic therapy is greatly reduced and a hypothesis for the lack of response after antiangiogenic treatment is an alteration of the tumor phenotype in a highly infiltrative compartment that is angiogenic-independent (Beal et al 2011) .
A final implication of our results affects the transition from low grade glioma (LGG) to higher grades for the GBMs. Although many factors may induce the transition, the simplest explanation involves the development of hypoxic areas (Swanson et al 2011) . This idea matches well with the fact that several distinctive features between LGGs and HGGs are related to the presence of hypoxia in the later ones: pseudopalisades and necrosis, microvascular proliferation and a higher cellularity originating the hypoxic events (Brat and Van Meir 2004; Martinez-González et al. 2012) . Our results show that preventing vessel failure and the cascade of malignant transformations associated to hypoxia may result in a delay in the appearance of the more invasive phenotype. Thus LGGs suspicious to undergo the malignant transformation might benefit from anti-thrombotic medication to avoid the degeneration into HGGs.
Because of the relevant role of hypoxia-inducible factors on the aggressiveness and tumorgenic capacity of glioma cells (Li et al 2009) stabilization of HIF-1α has been also recently proposed as an attractive therapeutic target (Semenza 2003) . Our study points out yet another reason based on purely dynamical considerations. The stabilization of HIF-1α would lead to smaller invasion speeds and thus to slower glioma progression if combined with therapies improving tumor oxygenation.
Critical points
In summary, we have studied a simple model that shows the large impact of localized in time hypoxic events in the progression of gliomas. The mechanism is based on a low amplitude wave of hypoxic cells that seed the normal tissue in advance and accelerate the progression of the wave of more proliferative cells. The key parameter in this process is the time that hypoxic phenotype cells take to revert to the normoxic phenotype under oxic environmental conditions.
We have also provided some theoretical results including necessary conditions for having persistent finite amplitude solitons composed of cells with an hypoxic phenotype. From a quantitative point of view, the hypoxic front wave has two 'components' one much bigger than the other one. We have proven that the speed wave of the 'smallest' component of the hypoxic front wave converges to c * hn . The stability of those wave packets is a difficult mathematical problem, due to the essential spectrum and will be studied in the future.
A Critical points
Let (vn, v h ) be a solution of (4.1) and define V (ξ) = (V 1 , V 2 , V 3 , V 4 ) = (vn, v ′ n , v h , v ′ h ), then
A point V 1 ,V 2 ,V 3 ,V 4 is an equilibrium of (A.1) if F V 1 ,V 2 ,V 3 ,V 4 = (0, 0, 0, 0). We will classify these linear equilibria by their generalized eigenspaces, according to the sign of the real part of the eigenvalues of the linearization, giving the decomposition R 4 = E u ⊕ E s ⊕ E c into the direct sum of unstable, stable and center eigenspaces. More precisely:
(a) Assume that c > c * n .
Theorem A5 For any 0 < τn < ∞ and τ hn > 0, the equilibrium (V 1 , V 2 , V 3 , V 4 ) = (1, 0, 0, 0) is a saddle point, dim(E u ) = dim(E s ) = 2, and E u is tangent to the space span[(1, λ 1+ , 0, 0), (0, 0, 1, λ 2+ )] at (1, 0, 0, 0). Whenever τ hn , τn > 0, the eigenvalues λ 1± , λ 2± ∈ R and satisfy λ 1− < 0 < λ 1+ , λ 2− < 0 < λ 2+ , and as a consequence, the non-trivial equilibria (1, 0, 0, 0) T is a saddle point, and dim(E u ) = dim(E s ) = 2. Moreover, it is not difficult to prove that E u is tangent to span[(1, λ 1+ , 0, 0), (0, 0, 1, λ 2+ )] at (1, 0, 0, 0), which completes the proof.
Proof
